Tumor type | Prevalence | References |
---|---|---|
Appendiceal | 0.56%–2% | |
Cholangiocarcinoma | 4% | Ross et al. 2014 [38] |
Colorectal | 0.2%–0.5% | Gatalica et al. 2019 [7]; Creancier et al. 2015 [39]; Forsythe et al. 2020 [37] |
Glioblastoma | 3% | Zheng et al. 2014 [40] |
High-grade glioma | 21.21% | Forsythe et al. 2020 [37] |
High-grade glioma, pediatric | 5.3%–6.19% | |
Head and neck cancer | 0.5% | Stransky et al. 2014 [12] |
Infantile fibrosarcoma | 70%–91% | Amatu et al. 2019 [2]; Vaishnavi et al. 2015 [9]; Forsythe et al. 2020 [37] |
Low-grade glioma | 0.4%–0.88% | |
Low-grade glioma, pediatric | 1.61% | Forsythe et al. 2020 [37] |
Lung adenocarcinoma | 0.1% | Gatalica et al. 2019 [7]; Farago et al. 2015 [42]; Forsythe et al. 2020 [37] |
Melanoma | 0.3% | |
Papillary thyroid carcinoma | < 5%–25% | Brzezianska et al. 2006 [43]; Greco et al. 2010 [44]; Wajjwalku et al. 1992 [45]; Said et al. 1994 [46]; Butti 1995 [47]; Delvincourt et al. 1996 [48]; Bounacer et al. 2000 [49]; Forsythe et al. 2020 [37] |
Pilocytic astrocytoma | 3% | Jones et al. 2013 [50] |
Secretory breast carcinoma | 92.87% | |
Secretory carcinoma of salivary gland | 66%–93% | Skalova et al. 2014 [52]; Skalova et al. 2010 [53]; Forsythe et al. 2020 [37] |
Soft tissue sarcoma (non-infantile fibrosarcoma) | < 5% | Demetri et al. 2020 [55] |
Spitzoid melanoma | 16% | Wiesner et al. 2014 [54] |